⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 17, 2024Clinical Lung CancerOpen Access

A Novel EGFR Germline Mutation in Lung Adenocarcinoma: Case Report and Literature Review

Parth Sharma Himil Mahadevia Sreekanth Donepudi Lara Kujtan Beth Gustafson Ben Ponvilawan Ammar Al‐Obaidi Janakiraman Subramanian Dhruv Bansal

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

While most molecular testing focuses on somatic alterations in patients with non-small cell lung cancer, evidence is growing regarding the presence of germline lung cancer mutations. The most common lung cancer germline mutation is EGFR T790M.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sharma et al. (2024) studied this question.

synapsesocial.com/papers/68e6eaccb6db6435876661b8 https://doi.org/10.1016/j.cllc.2024.04.009

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Prevalence and Clinical Implications of Somatic and Germline EGFR Mutations in Patients with Non-Small-Cell Lung CancerReview · 2026
2Germline EGFR T790M in Lung Cancer: Prevalence, Clinical Impact, and Implications for Hereditary Risk2025 · 2 citations
3Germ-line mutations in epidermal growth factor receptor (EGFR) are rare but may contribute to oncogenesis: A novel germ-line mutation in EGFR detected in a patient with lung adenocarcinomaOriginal Research · 2011 · 35 citations
4Germline EGFR T790M mutation and lung cancer riskOriginal Research · 2026
5Rare compound mutation of EGFR L858R and E709A identified in both solid tumor and liquid biopsy of a lung adenocarcinoma patient2024

The clinicopathological features and possible physiological mechanisms of only the EGFR-T790M primary mutation in patients with lung adenocarcinoma2024
Targeted next-generation sequencing of 491 lung cancers in clinical practice: Implications for future detection strategy and targeted therapy2024
Benefits of osimertinib treat a lung adenocarcinoma patient with germline EGFR T790M, somatic EGFR 19-Del, TP53 and PIK3CA mutations2024
Risk of developing a subsequent primary lung cancer among adult non-lung cancer survivors: implications for lung cancer screening and supportive careClinical Lung Cancer · 2026
Osimertinib plus platinum-based chemotherapy in patients with EGFR-mutated advanced NSCLC post-progression on first-line osimertinib: ORCHARDClinical Lung Cancer · 2026

More from Clinical Lung Cancer

More from University of Missouri–Kansas City

More from Saint Luke's Hospital

More from Virginia Cancer Institute